CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Practice detailsWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug2221 Selinexor Wiki 0.50
drug726 Data record Wiki 0.50

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.06
D045169 Severe Acute Respiratory Syndrome NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There are 2 clinical trials

Clinical Trials


1 Gastrointestinal Endoscopy in the Era of COVID-19: a Multinational Survey

A questionnaire containing some critical questions about practice inside GI endoscopy units in different countries will be distributed via emails. Responses will be collected in an online platform and data will be analyzed to reveal the effect of SARS-CoV-2 pandemic on different aspects of GI endoscopy practice in the studied countries.

NCT04342637 COVID-19 Other: Practice details

Primary Outcomes

Description: To evaluate the validity of different GI societies recommendations applied locally and how effective they are in preventing transmission in endoscopy units through reporting any new cases developing COVID-19 within two weeks of doing endoscopy (whether a patient or health-care worker)

Measure: Effect of GI societies recommendations on prevention of SARS-CoV-2 infection

Time: 4- 6 months

Description: To measure the percentage change in performed endoscopic procedure in response to COVID-19 in different centers of the world and the alternative solutions given to overcome this problem.

Measure: To measure the percentage change in performed endoscopic procedure in response to COVID-19

Time: 4- 6 months

Secondary Outcomes

Description: Effect of COVID-19 precautions on procedure time

Measure: Effect of COVID-19 precautions on procedure time

Time: 4- 6 months

Description: Effect of COVID-19 precautions on prolongatIon of time of disinfection

Measure: Effect of COVID-19 precautions on time of disinfection

Time: 4- 6 months

Description: Effect of COVID-19 precautions on the ability of the endoscopist to finish the procedure successfully

Measure: Effect of COVID-19 precautions on procedure success

Time: 4- 6 months

Description: Effect of COVID-19 precautions on occurrence of complications

Measure: Effect of COVID-19 precautions on complications

Time: 4- 6 months

Description: Effect of COVID-19 precautions on change of working time (prolongation or shortening)

Measure: Effect of COVID-19 precautions on working time

Time: 4- 6 months

Description: Effect of COVID-19 precautions on change of staff number

Measure: Effect of COVID-19 precautions on staff number

Time: 4- 6 months

2 Observational Study to Assess the Health Status of Transplanted Patients (Kidney or Pancreas or Pancreatic Islet Transplantation) at Transplant Medicine Unit (MITRA) During the COVID-19 Pandemic

Collect informations on the health status of transplanted patients (kidney, kidney / pancreas, pancreas or pancreatic islet) during the COVID-19 pandemic. All informations will be collected by short questionnaire via phone.

NCT04377776 Kidney Transplant Pancreas Tranplant Pancreatic Islet Transplantation Other: Practice details

Primary Outcomes

Description: Global Prevalence of COVD-19 infection in transplanted patients

Measure: Global Prevalence of COVID-19 TX

Time: From 01st February 2020 to 18 May 2020

Description: Hospitalization rate of transplanted patients

Measure: Hospitalization rate in COVID-19 TX

Time: From 01st February 2020 to 18 May 2020

Secondary Outcomes

Description: Correlation between type of transplantation to COVID-19 virus infection

Measure: Correlation COVID-19 TX and type of transplantation

Time: From 01st February 2020 to 18 May 2020

Description: Prevalence COVID-19 virus infection in transplanted patients in italian provinces

Measure: Prevalence of COVID-19 TX in italian provinces

Time: From 01st February 2020 to 18 May 2020

Description: Prevalence of different symptoms in COVID-19 virus infection in transplanted patients

Measure: Symptoms in COVID-19 TX

Time: From 01st February 2020 to 18 May 2020

Description: Correlation between comorbidities to COVID-19 virus infection

Measure: Correlation COVID-19 TX and comorbidities

Time: From 01st February 2020 to 18 May 2020

Description: Impact of different therapies on COVID-19 virus infection in transplanted patients

Measure: COVID-19 TX Therapies

Time: From 01st February 2020 to 18 May 2020

Description: Impact of COVID-19 virus infection in transplanted patients family settings

Measure: COVID-19 TX in family settings

Time: From 01st February 2020 to 18 May 2020


No related HPO nodes (Using clinical trials)